Dr. Muhammad Tanweer Khan
Dr. Muhammad Tanweer Khan
Associate Professor
University of Gothenburg

Tanweer a microbiologist, associate professor, and co-founder with 15 years of gut microbiota research experience, is known for key discoveries like 'the gas tube,' the Simulated Human Intestinal Redox Model (SHRIM), and process and product development for next-generation probiotics. He founded Roxbiosens, Metabogen, and Implexion Pharma, and is a Scientist at Biogaia AB, focusing on next generation probiotic development and clinical trials. His recent Nature publication on Extremely Oxygen-Sensitive (EOS) probiotics marks a significant advancement in the field.